This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
India’s commitment to conserving its rich biodiversity is reflected in the Biological Diversity Act (BDA) of 2002. For inventors seeking to patent inventions involving biological resources, the Act mandates obtaining approval from the National Biodiversity Authority (NBA). Requirement of NBA Approval in relation to Patents?
Artificial intelligence is changing industry and society, and metrics at the US Patent and Trademark Office (USPTO) reflect its impact. In a recent publication, the USPTO indicated that from 2002 to 2018 the share of all patentapplications relating to artificial intelligence grew from 9% to approximately 16%. Part Two.
Artificial intelligence is changing industry and society, and metrics at the US Patent and Trademark Office (USPTO) reflect its impact. In a recent publication, the USPTO indicated that from 2002 to 2018 the share of all patentapplications relating to artificial intelligence grew from 9% to approximately 16%. Part Three.
This second part continues where that post left off, and brings us analysis on whether or not, for the purposes of maintaining a divisional application, there must be a plurality of inventions in the claims of the parent application. When can/not a PatentApplication be Divided? Part II: Claims & Pluralities.
With South Africa’s patent office having recently granted the first patent to an AI inventor, and an Australian court ruling in favor of AI inventorship, it’s time to review how we got here—and where we’re going. If AI-related patentapplications and grants are on the uptick, what was the problem with DABUS?
PatentNext Summary: Artificial Intelligence (AI) PatentApplication filings continue their explosive growth trend at the U.S. Patent Office (USPTO). At the end of 2020, the USPTO published a report finding an exponential increase in the number of patentapplication filings from 2002 to 2018.
However, this 2002 decision did not define whether AI technology can be an inventor. The two creators listed DABUS as the inventor on two applications for patents for the inventions of a light beacon and a food container. On appeal, Judge Brinkema agreed that Thaler and Abbott could not list DABUS as the inventor on a patent.
Artificial intelligence is changing industry and society, and metrics at the US Patent and Trademark Office (USPTO) reflect its impact. In a recent publication, the USPTO indicated that from 2002 to 2018 the share of all patentapplications relating to artificial intelligence grew from 9% to approximately 16%. 55942 (Oct.
Looking at Traditional Knowledge and Patents: The MHC recently upheld the Controller’s rejection of a patentapplication for being based on Panchagavya, a form of Traditional Knowledge. Section 3(p) prohibits granting patents based on the claimed invention/process containing TK directly or in effect.
We recently came across two decisions by the Indian Patent Office (IPO) in which patent claim applications concerning two nicotine delivery devices were rejected on the ground of the same being affected by section 3(b) of the Indian Patents Act, 1970. The first decision concerns application no. a tobacco company.
The COVID vaccines do not genetically modify your DNA, but Juno’s patented CAR T-Cell therapy certainly does. The patent claims a nucleic acid polymer (DNA/RNA) that encodes for a particular “chimeric T cell receptor.” But, the patent does not actually disclose the DNA sequence of such a binding element.
To be granted a patent, an invention by the applicant must be novel, non-obvious, and must be such that can be manufactured or used in industry. Besides these basic, requirements an invention must also not fall under the criteria of non-patentable subject matter as discussed in Sections 3, 4, and 5 of the Patents Act, 1970 (“ Act ”).
The evergreening of patents is a common element of pharmaceutical patents. The evergreening of patents is a common element of pharmaceutical patents. The most crucial method that global medicine enterprises use is drug evergreening of patents.
8(1) Regulation 6/2002, the Düsseldorf Higher Regional Court (OLG Düsseldorf) sent a referral to the CJEU on just this issue ( C-684/21 ). 8(1) Regulation 6/2002. One of the two questions at issue in the case was the role that patent documentation plays in establishing the technical functionality of the features of a design.
Reversing what seemed like a victory for supporters of AI-owned intellectual property, the full bench of the Federal Court of Australia has confirmed the majority view of the world: only human inventors can own patent rights to their creations. Previously, IPilogue reported that Australia has granted patent ownership to an AI inventor.
A quick glance at last week analysis of wrongful obtainment in the Indian patent landscape, discussing Delhi High Courts jurisdiction in ANI vs OpenAI, and the implications of a MoU between screen writers and music composers. For more details see their call for applications in this post. Bharathwaj Ramakrishnan discusses this issue.
Here is our recap of last week’s top IP developments including summaries of the posts on IPO’s patentapplication rejection of HIV drug Dolutegravir, another judgement in the long-running Section 3(k) saga, this time on the patentability of business methods and the DHC IPD’s Annual Report 2023-24. Anything we are missing out on?
of the Patents Cooperation Treaty Regulations (a provision that provides for condonation of delay by a period of one month with respect to the submission of national phase patentapplication) in the petitioner’s favour. The petitioner approached the High Court against the decision of the Controller of Patents.
Types of IPR Basically, there are four types of IPR Patent Trademarks Copyrights Trademark and Metaverse Trademark is the visual symbol that differentiate between trademarked goods and services from each other. Patent and Metaverse Over the past ten years, there have been an increasing number of metaverse-related patent filings.
In light of the upcoming WIPO Diplomatic Conference on Genetic Resources and Traditional Knowledge, Prashant Reddy brings us a post highlighting India’s sub-par experience with its own Biological Diversity Act, 2002. These activities included publishing papers, filing of patentapplications or where research results were shared.
Last week we published 3 posts on the E&Y’s report on music publishing in India, MHC’s judgement clarifying the jurisdiction of a High Court to hear writ petitions against orders of the Patent Office and the CGPDTM’s open house help desk portal. The Controller of Patents. Anything we are missing out on? Sun Pharma Laboratories Ltd.
agreeing that the asserted claims are directed to patent ineligible subject matter under 35 U.S.C. § The patents at issue were directed to methods of facilitating remote gambling activity using devises equipped with GPS. Claim 2 of the US10255755 (2002 priority date), was the most discussed claim in the case. Beteiro, LLC v.
Reddy and Pai argue that even if a waiver results in a suspension of certain rules, vaccines cannot be manufactured without technology transfer and by merely waiving patents. We have written here about the disclosure problem in the patent system – that creates a gap between sufficiency of disclosure and enablement and manufacturing.
In 2002, Mark Chester, an engineer at Koso America, Inc. (“Koso”), participated in a project to create a new valve for a hydraulic actuator. Chester and MEA filed a related patentapplication, which was approved in part. ” REXA, Inc. Chester , — F.4th 4th —, 2022 WL 2981167, at *6 (7th Cir.
2022) focuses on the classic patent law question of whether the inventor’s pre-filing sales activity serve to bar the patent from issuing. Sunoco’s patents cover systems for blending butane into gasoline. The patents here are pre-AIA and so the on-sale bar included a one-year pre-filing grace period.
What is invented through biotechnological processes must be protected through patent protection lest a third person misuses the same. SCOPE FOR PATENT PROTECTION: The growth of patents in biotechnology has been remarkable in recent decades, driven by several key factors that reflect the increasing importance and complexity of this field.
However, this is if the applicable time period requirements are met: twelve months from the first application in the case of patents and six months from the first application in the case of industrial designs and trademarks.
Patentable requirements. To be granted a patent, an invention by the applicant must be novel, non-obvious, and such that it can be manufactured or used in industry. However, even after fulfilling these requirements, an additional requirement is to be fulfilled by the inventor/applicant, and that is ‘enablement.’
Artificial intelligence is changing industry and society, and metrics at the US Patent and Trademark Office (USPTO) reflect its impact. In a recent publication, the USPTO indicated that from 2002 to 2018 the share of all patentapplications relating to artificial intelligence grew from 9% to approximately 16%. Part Three.
Defensive protection strategies may also include documenting traditional medical knowledge systems in order to oppose or invalidate patents that claim inventions which root from such systems. These initiatives have attempted to prevent patents from being erroneously granted. Turmeric patent case. Das and Hari Har P.
Artificial intelligence is changing industry and society, and metrics at the US Patent and Trademark Office (USPTO) reflect its impact. In a recent publication, the USPTO indicated that from 2002 to 2018 the share of all patentapplications relating to artificial intelligence grew from 9% to approximately 16%.
In the August 2021 edition of our monthly Texas Patent Litigation Monthly Wrap-Up, we cover a case concerning the doctrine of prosecution laches. 2021), the Personalized Media court held that the asserted patent U.S. 8,191,091 (the “’091 Patent”) is unenforceable under the doctrine of prosecution laches. Patent Nos.
The Federal Circuit had previously broadly applied the non-statutory doctrine to prevent a prior owner of patent rights (the “assignor”) from later challenging the validity of those rights. The patentapplication was in this state — with only permeable member claims — when the assignment at issue took place.
ABSTRACT The legal dispute between Bajaj and TVS Motors centers around the alleged unauthorized use of the DTSi patent. This case holds significant importance not only due to the financial implications for the involved parties but also due to its implications for the application of the doctrine of pith and marrow. Motor Company Ltd.)
At its core, the case relates to whether the right to file a patentapplication in the future is covered by the same provisions relating to the right to an existing patent or patentapplication. Trade Marks Many would consider the shape of Dior’s Saddle bag to be iconic.
We’ve tried to represent a diversity of subject matter also in this list, so it’s a mixed bag of cases dealing with patents, trademarks, copyright law etc. Controller of Patents where the Court emphasised the requirement of the plurality of invention in divisional applications and held that plurality should be disclosed in the claims.
Artificial intelligence is changing industry and society, and metrics at the US Patent and Trademark Office (USPTO) reflect its impact. In a recent publication, the USPTO indicated that from 2002 to 2018 the share of all patentapplications relating to artificial intelligence grew from 9% to approximately 16%. 55942 (Oct.
The outcome here shows value for the intentional use of means-plus-function limitations as a mechanism for expanding patent scope when genus claims are otherwise unavailable. Even before the decision, biotech -focused patent attorneys have been searching for ways to capture their clients innovations with broad enough coverage.
From 2002 to 2018, annual AI patentapplications increased from 30,000 to 60,000. Additionally, the share of all patentapplications that contain AI increased from 9 percent to about 16 percent. With technological improvements, however, AI has upgraded from tool to creator.
From 2002 to 2018, annual AI patentapplications increased from 30,000 to 60,000. Additionally, the share of all patentapplications that contain AI increased from 9 percent to about 16 percent. With technological improvements, however, AI has upgraded from tool to creator.
This article summarizes the top developments reported on our blog and in patents, trademarks, and copyright law in 2021. Patents and the Magical World of Psychedelics by Bonnie Hassanzadeh. Introducing the College of Patent Agents & Trademark Agents. First Time Interpreting Patent Agent Privilege. David Vaver.
The written description requirement stipulates that a patent specification should sufficiently describe the claimed invention such that a skilled person would be convinced that the inventor had possession of the claimed subject matter at the filing date. During infringement proceedings relating to the patent, the defendant ( Kite Pharma Inc.)
From patents to copyrights, Trade Marks to trade secrets, the Berne Convention to TRIPS, knowing these accords is critical for individuals, corporations, and policymakers navigating the complexity of ‘intellectual property’ protection in the twenty-first century. ‘The
Unfortunately, what is good for the sharing of information is often not good for the patenting of inventions that arise from the research and products presented at these conferences. 2020 FC 621 , a poster was presented at a conference in Baltimore in 2002, 18 years previous. In Biogen Canada Inc. Taro Pharmaceuticals Inc.
We organize all of the trending information in your field so you don't have to. Join 9,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content